[Chemotherapy as primary therapy in non-radically operated ovarian cancer].
Forthwith the results of chemotherapy on advanced ovarian carcinoma are summarized. The following conclusions can be drawn: stages Ia and Ib of low malignancy degrees should receive follow-up treatment. Stages II and I of high malignancy degrees should receive radiotherapy to the whole abdomen. The value of intensive chemotherapy is examined. Stage II with residual tumor should undergo combined cis-platin treatment for 4 to 6 months. Stage III with residual tumor should receive intensive chemotherapy followed by a second-look operation and radiotherapy to the whole abdomen. The prognosis of cases with large residual tumors is very unfavorable so that the value of radical therapy must be further investigated.
K W
KW
Brunner
A
A
Goldhirsch
R
R
Greiner
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D010166:Palliative Care; D011379:Prognosis
D000970:Antineoplastic Agents; D002945:Cisplatin
Die Chemotherapie als Primärtherapie beim nicht radikal operierten Ovarialkarzinom.